Stroke, Vol 13, 842-847, Copyright © 1982 by American Heart Association
DJ Boarini, NF Kassell, JJ Olin and JA Sprowell
In 7 dogs anesthetized with halothane and nitrous oxide, dipyridamole was
administered in a loading dose of 1 mg/kg supplemented with 0.5 mg/kg every
30 minutes. Cardiovascular parameters and organ blood flows (using the
radioactive microsphere technique) were measured before and at 30 minute
intervals after each administration of dipyridamole, for a total of 105
minutes. The administration of dipyridamole was associated with a 20%
reduction in systemic arterial pressure, a 31% reduction in peripheral
vascular resistance, and a 13% increase in cardiac index. Cerebrovascular
resistance decreased 21%, but regional cerebral blood flow and metabolism
were unchanged. Blood flow to the heart increased 355% in the right
ventricle and 213% in the left ventricle. Blood flow to the jejunum
decreased 52% while blood flow to the kidney and liver decreased slightly.
The circulatory effects of dipyridamole are probably related to its
interference with the inactivation of endogenous adenosine. The
differential effects of dipyridamole on organ flow are similar to those
seen following the IV infusion of adenosine.
ARTICLES
The effect of intravenous dipyridamole on the cerebral and systemic circulations of the dog
This article has been cited by other articles:
![]() |
H. Ito, T. Kinoshita, Y. Tamura, I. Yokoyama, and H. Iida Effect of Intravenous Dipyridamole on Cerebral Blood Flow in Humans : A PET Study Stroke, August 1, 1999; 30(8): 1616 - 1620. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |